298 related articles for article (PubMed ID: 31301458)
1. Diagnosis and management of latent tuberculosis infection in Asia: Review of current status and challenges.
Paton NI; Borand L; Benedicto J; Kyi MM; Mahmud AM; Norazmi MN; Sharma N; Chuchottaworn C; Huang YW; Kaswandani N; Le Van H; Lui GCY; Mao TE
Int J Infect Dis; 2019 Oct; 87():21-29. PubMed ID: 31301458
[TBL] [Abstract][Full Text] [Related]
2. Latent tuberculosis infection: recent progress and challenges in South Korea.
Jeon D
Korean J Intern Med; 2020 Mar; 35(2):269-275. PubMed ID: 32131570
[TBL] [Abstract][Full Text] [Related]
3. Latent tuberculosis infection: Opportunities and challenges.
Chee CBE; Reves R; Zhang Y; Belknap R
Respirology; 2018 Oct; 23(10):893-900. PubMed ID: 29901251
[TBL] [Abstract][Full Text] [Related]
4. [Compliance with latent tuberculosis treatment: a public health challenge].
Bishara H; Ore L; Ravell DW
Harefuah; 2014; 153(3-4):167-70, 239, 238. PubMed ID: 24791558
[TBL] [Abstract][Full Text] [Related]
5. Trend and treatment outcomes of latent tuberculosis infection among migrant persons in Japan: retrospective analysis of Japan tuberculosis surveillance data.
Kawatsu L; Uchimura K; Ohkado A
BMC Infect Dis; 2021 Jan; 21(1):42. PubMed ID: 33422003
[TBL] [Abstract][Full Text] [Related]
6. The paradigm shift in the approach to management of latent tuberculosis infection in high tuberculosis burden countries.
Padmapriyadarsini C; Sachdeva KS; Nair D; Ramachandran R
Expert Rev Respir Med; 2021 Jul; 15(7):899-910. PubMed ID: 33302729
[No Abstract] [Full Text] [Related]
7. Relevance of latent TB infection in areas of high TB prevalence.
Sharma SK; Mohanan S; Sharma A
Chest; 2012 Sep; 142(3):761-773. PubMed ID: 22948580
[TBL] [Abstract][Full Text] [Related]
8. Identifying components for programmatic latent tuberculosis infection control in the European Union.
Sandgren A; Vonk Noordegraaf-Schouten JM; Oordt-Speets AM; van Kessel GB; de Vlas SJ; van der Werf MJ
Euro Surveill; 2016 Aug; 21(34):. PubMed ID: 27589214
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and Management of Latent Tuberculosis Infection: Updates.
Swain S; Kumar A; Vishwakarma VK; Aayilliath K A; Mittal A; Wig N
Infect Disord Drug Targets; 2024; 24(4):12-19. PubMed ID: 38031772
[TBL] [Abstract][Full Text] [Related]
10. Latent TB (LTBI) treatment: Challenges in India with an eye on 2025: "To Treat LTBI or not to treat, that is the question".
Rajpal S; Arora VK
Indian J Tuberc; 2020 Dec; 67(4S):S43-S47. PubMed ID: 33308671
[TBL] [Abstract][Full Text] [Related]
11. Treatment for latent tuberculosis infection in low- and middle-income countries: progress and challenges with implementation and scale-up.
Harries AD; Kumar AMV; Satyanarayana S; Takarinda KC; Timire C; Dlodlo RA
Expert Rev Respir Med; 2020 Feb; 14(2):195-208. PubMed ID: 31760848
[No Abstract] [Full Text] [Related]
12. Resistance to First-Line Antituberculosis Drugs in Washington State by Region of Birth and Implications for Latent Tuberculosis Treatment Among Foreign-Born Individuals.
Furukawa NW; Haider MZ; Allen SJ; Carlson SL; Lindquist SW
Am J Trop Med Hyg; 2017 Mar; 96(3):543-549. PubMed ID: 27994106
[TBL] [Abstract][Full Text] [Related]
13. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.
Houben RM; Dodd PJ
PLoS Med; 2016 Oct; 13(10):e1002152. PubMed ID: 27780211
[TBL] [Abstract][Full Text] [Related]
14. Primary Care Screening and Treatment for Latent Tuberculosis Infection in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Kahwati LC; Feltner C; Halpern M; Woodell CL; Boland E; Amick HR; Weber RP; Jonas DE
JAMA; 2016 Sep; 316(9):970-83. PubMed ID: 27599332
[TBL] [Abstract][Full Text] [Related]
15. National position statement for the management of latent tuberculosis infection.
Stock D;
Commun Dis Intell Q Rep; 2017 Sep; 41(3):E204-E208. PubMed ID: 29720068
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of isoniazid salvage therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders - A retrospective cohort study in Taiwan.
Huang SF; Chen MH; Wang FD; Tsai CY; Fung CP; Su WJ
J Microbiol Immunol Infect; 2018 Dec; 51(6):784-793. PubMed ID: 28739436
[TBL] [Abstract][Full Text] [Related]
17. Tumour necrosis factor antagonist and tuberculosis in patients with rheumatoid arthritis: an Asian perspective.
To KW; Reino JJ; Yoo DH; Tam LS
Respirology; 2013 Jul; 18(5):765-73. PubMed ID: 23627398
[TBL] [Abstract][Full Text] [Related]
18. Tuberculosis elimination and the challenge of latent tuberculosis.
Matteelli A; Sulis G; Capone S; D'Ambrosio L; Migliori GB; Getahun H
Presse Med; 2017 Mar; 46(2 Pt 2):e13-e21. PubMed ID: 28279508
[TBL] [Abstract][Full Text] [Related]
19. Awareness and perspectives on expansion of latent TB management among public-sector physicians and medical trainees in Delhi, India.
Sharma N; Basu S; Chopra KK; Sharma P
Indian J Tuberc; 2020 Apr; 67(2):208-212. PubMed ID: 32553313
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
